Cargando…

Editorial: Early diagnoses and treatments of uncommon breast cancers

Detalles Bibliográficos
Autores principales:	De Francesco, Ernestina Marianna, Vella, Veronica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623249/ https://www.ncbi.nlm.nih.gov/pubmed/36329883 http://dx.doi.org/10.3389/fendo.2022.1042226

Ejemplares similares

Editorial: A year in review: discussions in molecular and structural endocrinology
por: Couvineau, Alain, et al.
Publicado: (2023)

COVID-19 and Diabetes: The Importance of Controlling RAGE
por: De Francesco, Ernestina M., et al.
Publicado: (2020)

Editorial: A year in review: discussions in cancer endocrinology
por: Almeida, Madson, et al.
Publicado: (2023)

Editorial: Resistance to Endocrine Therapies in Cancer
por: Ranganathan, Prathibha, et al.
Publicado: (2020)

Editorial: Clinical and Molecular Epidemiology of Thyroid Cancer of Follicular Origin
por: Malaguarnera, Roberta, et al.
Publicado: (2018)

Editorial: Hormone Receptors and Breast Cancer
por: Brunetti, Antonio, et al.
Publicado: (2019)

Editorial: The Androgen Receptor in Breast Cancer
por: Tesei, Anna, et al.
Publicado: (2021)

Editorial: Hormones and receptors in breast cancer
por: Rosemblit, Cinthia, et al.
Publicado: (2023)

Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling
por: Vella, Veronica, et al.
Publicado: (2020)

Type 3 Deiodinase: Role in Cancer Growth, Stemness, and Metabolism
por: Ciavardelli, Domenico, et al.
Publicado: (2014)

Editorial: miRNAs and their role in endocrine cancer progression: from prognosis to treatment
por: Kushwaha, Prem Prakash, et al.
Publicado: (2023)

Editorial: Steroid hormone receptors and cell cycle in breast cancer
por: Fabris, Victoria T., et al.
Publicado: (2023)

Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?
por: Malaguarnera, Roberta, et al.
Publicado: (2017)

Editorial: Endocrinological factors for autism: prenatal biomarkers, early diagnosis and symptom treatment
por: Liang, Yujie, et al.
Publicado: (2023)

Editorial: Cancer-related hypercalcemia and potential treatments
por: Scappaticcio, Lorenzo, et al.
Publicado: (2023)

Editorial: Early Genetic and Clinical Diagnosis in MEN1
por: Lourenço, Delmar M., et al.
Publicado: (2020)

Editorial: Sex steroid hormones: effects on breast cancer risk and etiology
por: Mousa, Noha A., et al.
Publicado: (2023)

Editorial: Environmental stressors and metabolic disease
por: Zhang, Kezhong, et al.
Publicado: (2023)

Case Report: Uncommon cause of limp in the 21(st) century
por: Thiemann, Stephanie, et al.
Publicado: (2022)

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
por: Vella, Veronica, et al.
Publicado: (2017)

Activation of the S100A7/RAGE Pathway by IGF-1 Contributes to Angiogenesis in Breast Cancer
por: Muoio, Maria Grazia, et al.
Publicado: (2021)

Erratum: Case Report: Uncommon cause of limp in the 21st century
Publicado: (2023)

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment
por: Viola, David, et al.
Publicado: (2018)

Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management
por: Le Moli, Rosario, et al.
Publicado: (2022)

Editorial: Radiation as Risk Factor, Early Diagnosis, Therapy, and Follow-up of Differentiated Thyroid Cancer
por: Reiners, Christoph, et al.
Publicado: (2021)

Editorial: Gender pressure in cancer: susceptibility, progression and treatment of the neoplastic disease
por: Bacci, Marina, et al.
Publicado: (2023)

Editorial: New therapies in the treatment of sarcomas
por: Gartland, Alison, et al.
Publicado: (2023)

Editorial: Incretin agonists in the treatment of obesity
por: Sun, Xiaodong, et al.
Publicado: (2023)

Editorial: The role of the IGF axis in tumorigenesis and cancer treatment: From genes to metabolites
por: Mengzhe, Guo, et al.
Publicado: (2023)

Editorial: Endocrine organoids for modeling, drug development, and treatment of cancer and other diseases
por: Pidugu, Vijaya Kumar, et al.
Publicado: (2023)

Postpartum Thyroid Dysfunction in Women With Known and Newly Diagnosed Hypothyroidism in Early Pregnancy
por: Gao, Xiaotong, et al.
Publicado: (2021)

Editorial: Methods in cancer endocrinology
por: Martinelli, Chiara, et al.
Publicado: (2022)

Editorial: Cancer and Bone Metastasis
por: Mandal, Chandi C.
Publicado: (2019)

Editorial: Endocrinology in Cancer and Aging
por: Jockers, Ralf, et al.
Publicado: (2021)

Editorial: Hormone resistance in cancer
por: Phoenix, John T., et al.
Publicado: (2023)

Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy
por: Vella, Veronica, et al.
Publicado: (2023)

Editorial: Radiofrequency Ablation as an Alternative to Conventional Treatment
por: Pagano, Loredana, et al.
Publicado: (2022)

Editorial: Diagnosis, prevention and treatment in diabetic nephropathy
por: Rando, Maria Margherita, et al.
Publicado: (2022)

Editorial: Controversies in growth hormone treatment and diagnosis
por: Rapaport, Robert, et al.
Publicado: (2022)

Editorial: insights in cancer endocrinology 2021
por: Perks, Claire M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_07vch2jdbt9h5iqubkauut78mj